Connect with us


Photronics (PLAB) Reports Q4: Everything You Need To Know Ahead Of Earnings



Photronics (PLAB) Reports Q4: Everything You Need To Know Ahead Of Earnings

Semiconductor photomask manufacturer Photronics (NASDAQ:) will be announcing earnings results tomorrow before market hours. Here’s what to expect.

Last quarter Photronics reported revenues of $224.2 million, up 1.9% year on year, missing analyst expectations by 2.5%. It was a weak quarter for the company, with underwhelming revenue guidance for the next quarter and a miss of analysts’ revenue estimates.

Is Photronics buy or sell heading into the earnings? Find out by reading the original article on StockStory.

This quarter analysts are expecting Photronics’s revenue to grow 6.5% year on year to $224 million, slowing down from the 16% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.53 per share.

Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St’s revenue estimates once over the last two years, and has on average exceeded top line expectations by 3.7%.

Looking at Photronics’s peers in the semiconductor manufacturing segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. Marvell (NASDAQ:) Technology’s revenues decreased 7.7% year on year, beating analyst estimates by 1.3% and Nova reported revenue decline of 10.5% year on year, exceeding estimates by 4.6%. Marvell Technology traded up 2.2% on the results, and Nova was up 2.1%.

Read the full analysis of Marvell Technology’s and Nova’s results on StockStory.

There has been positive sentiment among investors in the semiconductor manufacturing segment, with the stocks up on average 11.5% over the last month. Photronics is up 9.3% during the same time, and is heading into the earnings with analyst price target of $28, compared to share price of $21.9.

The author has no position in any of the stocks mentioned.

Read the full article here